GEODE CAPITAL MANAGEMENT, LLC - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 77 filers reported holding UTAH MED PRODS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$5,911,034
-4.4%
68,724
+3.6%
0.00%0.0%
Q2 2023$6,181,769
-8.7%
66,328
-7.1%
0.00%0.0%
Q1 2023$6,767,620
+95636.6%
71,411
+1.5%
0.00%0.0%
Q4 2022$7,069
-99.9%
70,326
+0.8%
0.00%0.0%
Q3 2022$5,952,000
+1.8%
69,779
+2.5%
0.00%0.0%
Q2 2022$5,846,000
+10.6%
68,064
+15.7%
0.00%0.0%
Q1 2022$5,288,000
-6.8%
58,848
+3.7%
0.00%0.0%
Q4 2021$5,676,000
+8.8%
56,766
+1.0%
0.00%0.0%
Q3 2021$5,215,000
+8.3%
56,178
-0.8%
0.00%0.0%
Q2 2021$4,815,000
+3.1%
56,629
+5.0%
0.00%0.0%
Q1 2021$4,669,000
+4.3%
53,922
+1.5%
0.00%0.0%
Q4 2020$4,478,000
+5.7%
53,129
+0.2%
0.00%0.0%
Q3 2020$4,236,000
-8.7%
53,048
+1.3%
0.00%0.0%
Q2 2020$4,640,000
-4.3%
52,366
+1.6%
0.00%0.0%
Q1 2020$4,847,000
-55.0%
51,547
-48.3%
0.00%0.0%
Q4 2019$10,764,000
+122.9%
99,770
+98.0%
0.00%0.0%
Q3 2019$4,828,000
-3.7%
50,392
-3.8%
0.00%0.0%
Q2 2019$5,011,000
+8.7%
52,366
+0.2%
0.00%0.0%
Q1 2019$4,610,000
-44.2%
52,250
-47.4%
0.00%0.0%
Q4 2018$8,256,000
+81.5%
99,414
+105.9%
0.00%0.0%
Q3 2018$4,548,000
-10.2%
48,285
+4.9%
0.00%
-50.0%
Q2 2018$5,067,000
+19.9%
46,012
+7.6%
0.00%
+100.0%
Q1 2018$4,227,000
+5.6%
42,765
-13.1%
0.00%0.0%
Q4 2017$4,002,000
+20.0%
49,184
+8.5%
0.00%0.0%
Q3 2017$3,334,000
+9.1%
45,335
+7.4%
0.00%0.0%
Q2 2017$3,055,000
+30.9%
42,217
+12.6%
0.00%0.0%
Q1 2017$2,334,000
-10.7%
37,477
+4.3%
0.00%0.0%
Q4 2016$2,613,000
+23.7%
35,927
+1.7%
0.00%0.0%
Q3 2016$2,112,000
-5.3%
35,330
-0.2%
0.00%0.0%
Q2 2016$2,230,000
+2.4%
35,416
+1.6%
0.00%0.0%
Q1 2016$2,178,000
+23.9%
34,846
+16.0%
0.00%0.0%
Q4 2015$1,758,000
+10.0%
30,031
+1.2%
0.00%0.0%
Q3 2015$1,598,000
-7.3%
29,666
+2.6%
0.00%0.0%
Q2 2015$1,723,000
+0.5%
28,907
+0.9%
0.00%0.0%
Q1 2015$1,715,000
+108.9%
28,653
+109.5%
0.00%
Q4 2014$821,000
+27.7%
13,677
+3.6%
0.00%
Q3 2014$643,000
-2.3%
13,204
+3.2%
0.00%
Q2 2014$658,000
-0.3%
12,792
+12.0%
0.00%
Q1 2014$660,000
+32.5%
11,420
+31.0%
0.00%
Q4 2013$498,000
+12.9%
8,717
+17.4%
0.00%
Q3 2013$441,000
+17.0%
7,422
+6.9%
0.00%
Q2 2013$377,0006,9460.00%
Other shareholders
UTAH MED PRODS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Clean Yield Group 49,094$3,535,0001.48%
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 27,464$1,988,0000.72%
Ativo Capital Management LLC 16,525$1,196,0000.33%
Ancora Advisors LLC 55,159$3,993,0000.26%
ISTHMUS PARTNERS, LLC 10,754$779,0000.23%
Cardinal Capital Management 9,180$665,0000.22%
Acrospire Investment Management LLC 1,919$139,0000.13%
Penobscot Investment Management Company, Inc. 4,000$290,0000.09%
TFS CAPITAL LLC 3,226$234,0000.09%
WCM INVESTMENT MANAGEMENT, LLC 81,912$5,930,0000.09%
View complete list of UTAH MED PRODS INC shareholders